Lobbying

Oxygenium's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Medical/Disease Research/Clinical Labs.

Oxygenium

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

No lobbying spend in this period.

Oxygenium lobbying by quarter
Oxygenium lobbying by quarter
QuarterAmountReports
Q4 2022$01
Q1 2023$01
Q2 2023$01
Q3 2023$01
Q4 2023$01
Q1 2024$01
Q2 2024$01
Q3 2024$01
Q4 2024$01
Q1 2025$01
Q2 2025$01
Q3 2025$01
Q4 2025$01
Q1 2026$01
Q2 2026$01
Q3 2026$00

By issue

  • Budget and appropriations$0 · 8 reports
  • Medical research and clinical labs$0 · 5 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES13 reports
  • SENATE13 reports

Firms it paid

Firm
Burrell International Group$015 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/19for Q2Burrell International GroupUnder $5,000
04/17for Q1Burrell International GroupUnder $5,000
01/14for Q4 2025Burrell International GroupUnder $5,000
25/10/18for Q3 2025Burrell International GroupUnder $5,000
25/07/18for Q2 2025Burrell International GroupUnder $5,000
25/04/17for Q1 2025Burrell International GroupUnder $5,000
25/01/15for Q4 2024Burrell International GroupUnder $5,000
24/10/17for Q3 2024Burrell International GroupUnder $5,000
24/07/16for Q2 2024Burrell International GroupUnder $5,000
24/04/18for Q1 2024Burrell International GroupUnder $5,000
24/01/16for Q4 2023Burrell International GroupUnder $5,000
23/10/19for Q3 2023Burrell International GroupUnder $5,000
23/07/18for Q2 2023Burrell International GroupUnder $5,000
23/04/19for Q1 2023Burrell International GroupUnder $5,000
23/01/18for Q4 2022Burrell International GroupUnder $5,000